Is Zinc Good for PCOS? Zinc Effects and Benefits

What Is the Link Between Zinc and PCOS?

Women with PCOS show measurably lower serum zinc than healthy controls. A 2019 cross-sectional study published in Biological Trace Element Research (N=100) found mean serum zinc was 12.3% lower in women with PCOS compared to age-matched controls, and the deficit correlated with higher free androgen index scores (1). That correlation matters because zinc is not a passive bystander. It acts as a cofactor for more than 300 enzymes, several of which regulate steroidogenesis, glucose transport, and oxidative stress pathways that are disrupted in PCOS.

The three main domains where zinc shows measurable effect in PCOS are androgen excess, insulin resistance, and chronic low-grade inflammation. Each of these is explored below with specific trial data.

Why PCOS Depletes Zinc

Hyperinsulinemia, which affects an estimated 50 to 70% of women with PCOS, increases urinary zinc excretion. Higher insulin drives the kidneys to excrete more zinc, creating a cycle where the metabolic dysfunction of PCOS worsens the deficiency that then feeds back into worse metabolic control (2). Chronic low-grade inflammation also sequesters zinc into tissues as part of the acute-phase response, pulling it out of circulation.

How to Measure Zinc Status

Serum zinc is the most practical clinical test, though it underestimates total body zinc stores. The NIH Office of Dietary Supplements notes that no single biomarker perfectly reflects zinc status (3). A level below 70 mcg/dL is generally considered low. Women with PCOS and symptoms of androgen excess, irregular cycles, or poor glycemic control may benefit from testing even if standard labs have not flagged a deficiency.

Zinc and Androgen Levels in PCOS

Elevated androgens drive the most visible symptoms of PCOS: hirsutism, acne, and hair thinning. Zinc reduces androgen burden through at least two mechanisms. First, it inhibits 5-alpha-reductase, the enzyme that converts testosterone to its more potent form dihydrotestosterone (DHT). Second, it supports sex hormone-binding globulin (SHBG) synthesis, which lowers the fraction of testosterone circulating in its free, biologically active form.

Evidence From Randomized Controlled Trials

A 2016 double-blind RCT published in the Journal of Obstetrics and Gynaecology (N=48) assigned women with PCOS to zinc sulfate 220 mg (equivalent to 50 mg elemental zinc) or placebo for 8 weeks. The zinc group showed a statistically significant reduction in serum testosterone (P<0.05) and a meaningful decrease in hirsutism scores on the modified Ferriman-Gallwey scale (4). Hirsutism scores dropped by an average of 2.3 points in the zinc arm versus 0.4 points in placebo.

A 2015 RCT in Hormone and Metabolic Research (N=60) similarly found that 8 weeks of zinc sulfate supplementation reduced DHEAS concentrations by approximately 13% compared to baseline, with no significant change in the placebo group (5).

Acne and Hair Loss

Both acne and androgenic alopecia in PCOS are partly DHT-mediated. Because zinc inhibits 5-alpha-reductase, lower DHT levels can reduce sebum production and slow follicular miniaturization. A 12-week open-label trial published in Dermatology found oral zinc gluconate reduced inflammatory acne lesion counts by 31.2% in women with elevated androgens (6). Hair regrowth data in PCOS specifically remain limited, but the mechanistic rationale is consistent with the androgen-lowering evidence.

Zinc and Insulin Resistance in PCOS

Insulin resistance is present in roughly 65 to 70% of women with PCOS regardless of body weight. Zinc is a structural component of insulin itself. Each insulin hexamer contains two zinc ions required for proper storage and secretion from pancreatic beta cells. Deficiency impairs both insulin production and peripheral glucose uptake.

HOMA-IR and Fasting Insulin Data

A 2019 RCT in Biological Trace Element Research (N=66) randomized women with PCOS to 220 mg zinc sulfate or placebo for 12 weeks. Fasting insulin dropped by 4.2 mIU/L in the zinc group (P<0.01), and HOMA-IR (homeostatic model assessment of insulin resistance) fell from a mean of 3.8 to 2.9, a 23.7% reduction. The placebo group showed no significant change (7). These numbers are clinically meaningful. Metformin 500 mg twice daily typically reduces HOMA-IR by 20 to 30% over a similar period, so zinc's effect size is modest but in a comparable range for women who cannot tolerate metformin.

Zinc Transporter SLC30A8 and Beta-Cell Function

Zinc enters and exits pancreatic beta cells via the SLC30A8 transporter. Loss-of-function variants in SLC30A8 are associated with a nearly 65% increased risk of type 2 diabetes in genome-wide association studies (8). Women with PCOS already carry elevated lifetime diabetes risk (a 2012 meta-analysis in Fertility and Sterility estimated a relative risk of 2.87 for type 2 diabetes versus healthy controls). Supporting zinc status therefore addresses a genuinely high-stakes pathway.

Does Zinc Work Better With Inositol?

Myo-inositol and D-chiro-inositol are commonly paired with zinc in functional medicine protocols. A 2021 pilot study (N=40) published in Gynecological Endocrinology found combining myo-inositol 4 g daily with zinc 25 mg daily improved HOMA-IR more than myo-inositol alone (mean reduction 1.4 vs. 0.9, P<0.05), though the sample size limits generalizability (9). Larger trials are needed before this combination becomes standard of care.

Zinc and Inflammation in PCOS

PCOS carries a chronic inflammatory signature even in lean women. C-reactive protein (CRP), IL-6, and TNF-alpha are consistently elevated compared to healthy controls. Oxidative stress markers like malondialdehyde (MDA) are also higher. Zinc is a known antioxidant co-factor. It is required for the enzyme copper-zinc superoxide dismutase (Cu-Zn SOD), one of the body's primary defenses against reactive oxygen species.

CRP and Oxidative Stress Reductions

The 12-week RCT mentioned above (N=66, 7) also measured inflammatory markers. High-sensitivity CRP dropped by 1.1 mg/L in the zinc group (P<0.01). MDA, a marker of lipid peroxidation, fell by 18.4%. Total antioxidant capacity rose by 0.22 mmol/L. These changes occurred independently of body weight, suggesting zinc's anti-inflammatory effect is not simply a product of metabolic improvement.

Nitric Oxide and Vascular Health

Zinc supports endothelial nitric oxide synthase (eNOS) activity. Women with PCOS have higher rates of endothelial dysfunction, which increases cardiovascular risk. A smaller 8-week crossover study (N=30) published in Archives of Gynecology and Obstetrics found zinc supplementation improved flow-mediated dilation by 2.1 percentage points compared to placebo (10). The clinical implications for long-term cardiovascular protection in PCOS warrant further investigation, but the direction of effect is consistent.

Zinc and Menstrual Regularity and Fertility

Ovulatory dysfunction is the hallmark of PCOS. Zinc supports follicular development by acting as a cofactor for FSH receptor signaling and by protecting oocytes from oxidative damage. Low zinc at the time of ovulation may impair meiosis completion and fertilization.

Cycle Regularity Data

A double-blind placebo-controlled trial published in Iranian Journal of Reproductive Medicine (N=60) found that 50 mg elemental zinc daily for 8 weeks increased the proportion of women reporting regular menstrual cycles from 23% to 47% (P<0.05), compared to no change in the placebo group (11). The mechanism is likely indirect: lower androgens allow more regular LH pulsatility, which in turn permits follicle selection and ovulation.

Zinc and Ovarian Reserve

Anti-Mullerian hormone (AMH) is often elevated in PCOS, reflecting the large antral follicle pool that fails to reach dominance. Whether zinc directly modulates AMH remains unclear. One 2020 observational study (N=87) reported a negative correlation between serum zinc and AMH in PCOS (r = -0.34, P<0.01), but no intervention trial has yet targeted AMH as a primary endpoint (12). This is an area where prospective data are needed.

Practical Dosing and Safety: What Clinicians Recommend

The NIH sets the Recommended Dietary Allowance (RDA) for zinc at 8 mg/day for adult women and the Tolerable Upper Intake Level (UL) at 40 mg/day for long-term supplementation (3). Most PCOS trials used 25 to 50 mg of elemental zinc daily, which means some protocols exceed the UL. Exceeding 40 mg/day chronically can suppress copper absorption and cause nausea, particularly if taken on an empty stomach.

The Endocrine Society's 2023 guideline on PCOS management states that "micronutrient supplementation should be individualized based on documented deficiency or specific clinical indication, and used alongside lifestyle modification rather than as a standalone intervention." (13)

Choosing the Right Zinc Form

Not all zinc supplements deliver the same amount of elemental zinc. Zinc sulfate 220 mg contains approximately 50 mg elemental zinc. Zinc gluconate 100 mg contains about 14 mg elemental zinc. Zinc picolinate and zinc bisglycinate are often marketed as better-absorbed, though head-to-head bioavailability data comparing forms in women with PCOS specifically are sparse. The trials with the strongest PCOS data used zinc sulfate.

Timing and Interactions

Taking zinc with food reduces nausea but also reduces absorption if the meal is high in phytates (whole grains, legumes). Phytates bind zinc and block intestinal uptake. Calcium supplements taken at the same time can also reduce zinc absorption. Spacing zinc supplementation at least 2 hours from calcium and phytate-rich foods maximizes bioavailability.

Women on oral contraceptive pills for PCOS symptom management should note that estrogen-containing OCPs lower serum zinc by shifting it into tissues. This interaction may increase the likelihood of a functional deficiency even in women with normal dietary intake.

Copper Co-supplementation

Any supplemental zinc dose above 25 mg/day taken for more than 8 weeks should be paired with 1 to 2 mg of copper daily to prevent copper-deficiency anemia and neurological complications. The standard ratio used in supplementation protocols is roughly 15:1 zinc-to-copper by milligrams.

Zinc vs. Other PCOS Supplements: Where Does It Fit?

Women with PCOS are often presented with a long list of supplement options including myo-inositol, berberine, magnesium, vitamin D, N-acetyl cysteine (NAC), and omega-3 fatty acids. Zinc is not a replacement for any of these, but it does address mechanisms that some of the others do not.

Myo-inositol targets insulin signaling directly through the PI3K-Akt pathway. Vitamin D deficiency is present in 67 to 85% of women with PCOS and independently predicts worse metabolic outcomes. NAC provides glutathione precursors for antioxidant defense. Zinc's unique contributions are 5-alpha-reductase inhibition and direct androgenic hormone reduction, effects that myo-inositol and vitamin D do not replicate to the same degree.

A 2021 systematic review and meta-analysis in Advances in Nutrition (17 RCTs, N=1,139) ranked zinc among the top three micronutrients for PCOS-related androgen reduction, behind only NAC and vitamin D for the breadth of outcome improvement across metabolic, hormonal, and inflammatory domains (14).

For women whose primary concern is insulin resistance, combining zinc with berberine or myo-inositol under clinician supervision may produce additive benefit. For women whose primary concern is androgen-driven symptoms (hirsutism, acne), zinc's 5-alpha-reductase inhibition makes it particularly relevant.

Who Should Not Take High-Dose Zinc

Women with Wilson's disease (copper accumulation disorder) should avoid supplemental zinc without specialist guidance, as zinc displaces copper absorption and can destabilize copper balance in both directions. Pregnant women should not exceed the UL of 40 mg/day. Women already taking high-dose zinc through a multivitamin or other supplement stack should tally total daily intake before adding a separate zinc product.

Individuals with inflammatory bowel disease or celiac disease may have impaired zinc absorption, potentially requiring higher doses under physician monitoring. The FDA does not regulate zinc supplements for purity or potency with the same rigor applied to pharmaceuticals, so choosing a product with third-party verification (NSF International or USP certification) reduces the risk of mislabeling (15).

Lab Monitoring Protocol for PCOS Patients Starting Zinc

Before initiating zinc supplementation above dietary amounts, a baseline workup typically includes serum zinc, serum copper, complete blood count, fasting insulin, HOMA-IR, free testosterone, DHEAS, and hs-CRP. Repeating serum zinc, copper, and CBC at 8 to 12 weeks allows detection of copper depletion early. Hormonal and metabolic markers can be rechecked at 12 weeks to assess response. If serum zinc remains low at recheck despite supplementation, malabsorption syndromes or ongoing urinary losses from hyperinsulinemia may explain the resistance and warrant further evaluation.